Psychological stress and corticotropin-releasing hormone increase intestinal permeability in humans by a mast cell-dependent mechanism (Q44572735)

4 December 2017

Psychological stress and corticotropin-releasing hormone increase intestinal permeability in humans by a mast cell-dependent mechanism (English)

1 reference

4 December 2017

0 references

1 reference

10

1 reference

4 December 2017

12

Guy Boeckxstaens

1 reference

4 December 2017

Tim Vanuytsel

1

1 reference

4 December 2017

Sander van Wanrooy

2

1 reference

4 December 2017

Hanne Vanheel

3

1 reference

4 December 2017

Christophe Vanormelingen

4

1 reference

4 December 2017

Sofie Verschueren

5

1 reference

4 December 2017

Els Houben

6

1 reference

4 December 2017

Shadea Salim Rasoel

7

1 reference

4 December 2017

Joran Tόth

8

1 reference

4 December 2017

Lieselot Holvoet

9

1 reference

4 December 2017

Lukas Van Oudenhove

11

1 reference

4 December 2017

Kristin Verbeke

13

1 reference

4 December 2017

Jan Tack

14

1 reference

4 December 2017

language of work or name

English

0 references

publication date

23 October 2013

1 reference

4 December 2017

1 reference

4 December 2017

63

1 reference

4 December 2017

8

1 reference

4 December 2017

1293-1299

1 reference

The brain-gut axis in abdominal pain syndromes

4 December 2017

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305690

Psychosocial risk markers for new onset irritable bowel syndrome--results of a large prospective population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305690

Psychosocial factors at work and in every day life are associated with irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305690

Level of chronic life stress predicts clinical outcome in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305690

Brain-gut interactions in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305690

Eosinophils express muscarinic receptors and corticotropin-releasing factor to disrupt the mucosal barrier in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305690

Intestinal barrier function in health and gastrointestinal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305690

Importance of disrupted intestinal barrier in inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305690

Mucosal inflammation as a potential etiological factor in irritable bowel syndrome: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305690

Chronological assessment of mast cell-mediated gut dysfunction and mucosal inflammation in a rat model of chronic psychosocial stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305690

Chronic stress induces mast cell-dependent bacterial adherence and initiates mucosal inflammation in rat intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305690

Stress-induced barrier disruption of rat follicle-associated epithelium involves corticotropin-releasing hormone, acetylcholine, substance P, and mast cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305690

Critical role of stress in increased oesophageal mucosa permeability and dilated intercellular spaces

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305690

Maladaptive intestinal epithelial responses to life stress may predispose healthy women to gut mucosal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305690

Acute experimental stress evokes a differential gender-determined increase in human intestinal macromolecular permeability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305690

Combat-training increases intestinal permeability, immune activation and gastrointestinal symptoms in soldiers

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305690

Intestinal permeability: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305690

Urine sugars for in vivo gut permeability: validation and comparisons in irritable bowel syndrome-diarrhea and controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305690

Acute gastrointestinal permeability responses to different non-steroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305690

SPSS and SAS procedures for estimating indirect effects in simple mediation models

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305690

A prospective population-based study of triggers of symptomatic flares in IBD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305690

Predicting relapse in Crohn's disease: a biopsychosocial model

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305690

Effects of stressful life events on bowel symptoms: subjects with irritable bowel syndrome compared with subjects without bowel dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305690

Role of peripheral CRF signalling pathways in stress-related alterations of gut motility and mucosal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305690

MicroRNA-29a regulates intestinal membrane permeability in patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305690

Intestinal permeability in patients with irritable bowel syndrome after a waterborne outbreak of acute gastroenteritis in Walkerton, Ontario

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305690

In vivo and in vitro permeability in coeliac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305690

Larazotide acetate in patients with coeliac disease undergoing a gluten challenge: a randomised placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305690

The nutriceutical bovine colostrum truncates the increase in gut permeability caused by heavy exercise in athletes

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305690

The mast cell stabiliser ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305690

Time course of effect of disodium cromoglycate on exercise-induced asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305690

Chronic peripheral administration of corticotropin-releasing factor causes colonic barrier dysfunction similar to psychological stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305690

Corticotropin-releasing hormone (CRH) regulates macromolecular permeability via mast cells in normal human colonic biopsies in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305690

Psychological stress induces eosinophils to produce corticotrophin releasing hormone in the intestine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305690

The intestinal barrier and its regulation by neuroimmune factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305690

Effect of a corticotropin releasing hormone receptor antagonist on colonic sensory and motor function in patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305690

Do corticotropin releasing factor-1 receptors influence colonic transit and bowel function in women with irritable bowel syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305690

G-protein-coupled receptor 35 is a target of the asthma drugs cromolyn disodium and nedocromil sodium

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305690

Disodium cromoglycate inhibits activation of human inflammatory cells in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2013-305690

10.1136/GUTJNL-2013-305690

21 January 2018

Identifiers

DOI

1 reference

4 December 2017

1 reference